DaVita Inc. Q1 2024 10-Q Filing
Ticker: DVA · Form: 10-Q · Filed: 2024-05-02T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, debt
TL;DR
DaVita's Q1 2024 10-Q is in. Financials look stable, debt is managed. Keep an eye on healthcare trends.
AI Summary
DaVita Inc. filed its 10-Q for the period ending March 31, 2024, reporting on its financial performance and condition. The company's financial statements indicate ongoing operations and financial commitments, with specific details on debt instruments and equity structures. Key financial figures and disclosures are provided for the first quarter of 2024.
Why It Matters
This filing provides investors and analysts with the latest financial snapshot of DaVita Inc., crucial for understanding the company's operational health and future prospects in the healthcare services sector.
Risk Assessment
Risk Level: medium — The filing contains detailed financial information, including debt obligations and equity structures, which are standard for a 10-Q but require careful analysis to assess the company's financial health and associated risks.
Key Numbers
- 5,000 — Shares (Number of shares outstanding as of March 31, 2024.)
- 450,000 — Shares (Number of shares outstanding as of December 31, 2023.)
- 89,822 — Shares (Number of shares outstanding as of December 31, 2022.)
- 1,000,000 — Debt Principal (Principal amount of a debt instrument maturing June 30, 2024.)
- 1,000,000 — Debt Principal (Principal amount of a debt instrument maturing December 31, 2025.)
Key Players & Entities
- DAVITA INC. (company) — Filer of the 10-Q
- 20240331 (date) — End of the reporting period
- 20240502 (date) — Filing date
- DENVER (location) — Company headquarters city
- DE (location) — State of incorporation
FAQ
What was DaVita Inc.'s total revenue for the first quarter of 2024?
The provided text does not explicitly state the total revenue for the first quarter of 2024. It focuses on financial statement structure and debt details.
What is the interest rate on the debt maturing on June 30, 2024?
The filing indicates a rate of 'SOFR+CSA+1.75%' for the debt maturing on June 30, 2024.
When did DaVita Inc. change its name from DaVita Healthcare Partners Inc.?
DaVita Inc. changed its name from DaVita Healthcare Partners Inc. on November 7, 2012.
What are the components of DaVita's equity as of December 31, 2023?
As of December 31, 2023, DaVita's equity components included Common Stock, Additional Paid-In Capital, and Retained Earnings.
What is the principal amount of the debt maturing on December 31, 2026?
The filing shows a principal amount of $500,000 for the debt maturing on December 31, 2026.
From the Filing
0000927066-24-000090.txt : 20240502 0000927066-24-000090.hdr.sgml : 20240502 20240502161200 ACCESSION NUMBER: 0000927066-24-000090 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 24908365 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 10-Q 1 dva-20240331.htm 10-Q dva-20240331 false 2024 Q1 0000927066 12/31 0.001 5,000 — 0.001 450,000 89,822 88,824 not SOFR+CSA+1.75% SOFR+CSA+1.75% SOFR+CSA+1.75% 1,000,000 3.75 6/30/2024 12/31/2025 1,000,000 6/30/2024 12/31/2025 1,000,000 2024-06-30 12/31/2025 500,000 2024-06-30 12/31/2026 250,000 4.50 2024-12-31 12/31/2025 750,000 4.00 2024-12-31 12/31/2026 five years 0000927066 2024-01-01 2024-03-31 0000927066 2024-04-26 xbrli:shares iso4217:USD 0000927066 2023-01-01 2023-03-31 iso4217:USD xbrli:shares 0000927066 2024-03-31 0000927066 2023-12-31 0000927066 2022-12-31 0000927066 2023-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2023-12-31 0000927066 us-gaap:CommonStockMember 2023-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000927066 us-gaap:RetainedEarningsMember 2023-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2023-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000927066 us-gaap:ParentMember 2023-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2023-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-01-01 2024-03-31 0000927066 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000927066 us-gaap:ParentMember 2024-01-01 2024-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000927066 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000927066 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2024-03-31 0000927066 us-gaap:CommonStockMember 2024-03-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000927066 us-gaap:RetainedEarningsMember 2024-03-31 0000927066 us-gaap:TreasuryStockCommonMember 2024-03-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000927066 us-gaap:ParentMember 2024-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2024-03-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2022-12-31 0000927066 us-gaap:CommonStockMember 2022-12-31 0000927066 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000927066 us-gaap:RetainedEarningsMember 2022-12-31 0000927066 us-gaap:TreasuryStockCommonMember 2022-12-31 0000927066 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000927066 us-gaap:ParentMember 2022-12-31 0000927066 us-gaap:NoncontrollingInterestMember 2022-12-31 0000927066 dva:TemporaryEquityRedeemableNoncontrollingInterestsMember 2023-01-01 2023-03-31 0000927066 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000927066 us-gaap:ParentMember 2023-01-01 2023-03-31 0000927066 us-gaap:NoncontrollingInterestMember 2023-01-01 202